Thursday, July 20, 2017 12:52:36 PM
Here is thing number 1> (Judge for yourself)
ContraFect Corp, Inst Holders, 2Q 2017 (CFRX)
DOW JONES & COMPANY, INC. 2:11 AM ET 7/19/2017
The following table shows the largest shareholders in CONTRAFECT CORP COM (CFRX) for the quarter ended June 30, 2017, listed by holding size. The list represents up to 50 of the largest holders in the company.
Note: Unless otherwise mentioned the reporting date is 06/30/2017
Institution Shares Shares % Last
Held Changed Held Report
Baker Bros. Advisors LP 4,045,876 0 9.713 03/31
Cormorant Asset Management LLC 3,550,000 (292,966) 8.522 03/31
Adage Capital Management LP 2,500,000 0 6.002 03/31
Federated Global Investment Ma 2,000,000 0 4.801 03/31
Broadfin Capital LLC 1,429,109 0 3.431 03/31
Oracle Investment Management 1,182,032 0 2.838 03/31
The Vanguard Group Inc. 1,019,332 0 2.447 03/31
Birchview Capital LP 725,082 0 1.741 03/31
Alyeska Investment Group LP 712,614 (71,023) 1.711 03/31
Opus Point Partners Management 300,000 0 0.720 03/31
White Pine Capital LLC 253,045 (23,850) 0.607 03/31
Sunbelt Securities Inc. 200,000 0 0.480 03/31
Westfield Capital Management C 149,600 149,600 0.359 03/31
Goldman Sachs & Co. LLC (Priva 103,098 (95,359) 0.247 03/31
BlackRock Fund Advisors 90,998 0 0.218 03/31
Millennium Management LLC 78,225 (17,957) 0.188 03/31
Geode Capital Management LLC 71,850 486 0.172 03/31
Loeb Partners Corp. 25,725 0 0.062 03/31
Brown Advisory LLC 25,000 0 0.060 03/31
The Bank of New York Mellon Co 21,141 21,141 0.051 03/31
Rockefeller & Co. Inc. 20,251 3,297 0.049 03/31
Northern Trust Investments In 17,482 17,482 0.042 03/31
Klingenstein Fields & Co. LLC 15,000 0 0.036 03/31
AMG National Trust Bank 10,000 10,000 0.024 03/31
LPL Financial LLC 10,000 (9,260) 0.024 06/30
Recent CFRX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:24:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:41:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:30:55 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/03/2023 09:08:09 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/03/2023 04:16:01 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/30/2023 09:24:34 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/24/2023 08:06:07 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2023 08:05:56 PM
- ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study • GlobeNewswire Inc. • 10/16/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 03:15:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2023 12:00:18 PM
- ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development • GlobeNewswire Inc. • 09/19/2023 12:30:00 PM
- ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370 • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/14/2023 08:05:49 PM
- ContraFect to Present at the World Anti-Microbial Resistance Congress 2023 • GlobeNewswire Inc. • 08/28/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:10:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:18:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:10:59 PM
- ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 08:33:29 PM
- ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million • GlobeNewswire Inc. • 06/27/2023 12:30:00 PM
- ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company’s Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens • GlobeNewswire Inc. • 06/20/2023 12:59:00 PM
- ContraFect to Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens at ASM Microbe 2023 • GlobeNewswire Inc. • 06/08/2023 08:01:00 PM
- ContraFect Reports First Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/15/2023 12:00:00 PM
- ContraFect Announces First Patient Dosed in the Phase 1b/2 Study of Exebacase in Patients with Chronic Prosthetic Joint Infections of the Knee • GlobeNewswire Inc. • 04/26/2023 01:00:00 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM